APOH and autoimmune polyendocrinopathy: They are the main antiphospholipid antibodies (aPL), along with anti-β2-glycoprotein I (β2GPI) antibodies and lupus anticoagulant (LA), that characterize the autoimmune disease antiphospholipid syndrome (APS).